Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
JAMA Dermatol
; 153(7): 694-697, 2017 07 01.
Article
in En
| MEDLINE
| ID: mdl-28467522
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Keratoacanthoma
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
JAMA Dermatol
Year:
2017
Document type:
Article
Country of publication:
Estados Unidos